Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Home > Science Hub > Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
Back to the list

November 16, 2023

You might also be interested by

CellTalk Blog

How Antibody-Drug Conjugates (ADCs) Are Advancing Precision Cancer Treatment

February 18, 2025

More info

CellTalk Blog

Measuring Tumor Burden: Current and Emerging Approaches

January 24, 2025

More info

News

CellCarta Streamlines Kit Inventory Management for Clinical Sites with SLOPE-Powered Online Portal

January 14, 2025

More info

Webcasts & Webinars

Let's Talk: A Conversation with Dr. Thomas Powles

December 19, 2024

More info